{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:10:53Z","timestamp":1791252653221,"version":"4.1.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1993]]},"DOI":"10.1007\/bf00666430","type":"journal-article","created":{"date-parts":[[2004,11,27]],"date-time":"2004-11-27T18:38:30Z","timestamp":1101580710000},"page":"179-193","source":"Crossref","is-referenced-by-count":19,"title":["Breast cancer prevention through modulation of endogenous hormones"],"prefix":"10.1007","volume":"28","author":[{"given":"Darcy V.","family":"Spicer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm C.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","first-page":"121","volume-title":"Oral Contraceptives and Breast Cancer","author":"MP Vessey","year":"1990","unstructured":"Vessey MP: An overview of the benefits and risks of combined oral contraceptives (the Jephcott Lecture, 1989).In: Mann RD (ed) Oral Contraceptives and Breast Cancer. Parthenon Publishing Group, Park Ridge, 1990, pp 121?132."},{"key":"CR2","first-page":"796","volume":"256","author":"Centers for Disease Control","year":"1987","unstructured":"Centers for Disease Control: Combination oral contraceptive use and the risk of endometrial cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. JAMA 256:796?800, 1987.","journal-title":"JAMA"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","volume":"136","author":"AS Whittemore","year":"1992","unstructured":"Whittemore AS, Harris R, Itnyre J, and the Collaborative Ovarian Cancer Group: Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. II. Invasive epithelial cancers in white women. Am J Epidemiol 136:1184?1203, 1992.","journal-title":"Am J Epidemiol"},{"key":"CR4","volume-title":"Contraception","author":"MC Pike","year":"1993","unstructured":"Pike MC, Spicer DV. Oral contraceptives and cancer.In: Shoupe D, Haseltine F (ed) Contraception. Springer-Verlag, New York, 1993, in press."},{"key":"CR5","first-page":"3232","volume":"42","author":"B Henderson","year":"1982","unstructured":"Henderson B, Ross R, Pike M, Casagrande J: Endogenous hormones as a major factor in human cancer. Cancer Res 42:3232?3239, 1982.","journal-title":"Cancer Res"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0021-9681(87)80009-7","volume":"40","author":"M Pike","year":"1987","unstructured":"Pike M: Age-related factors in cancer of the breast, ovary and endometrium. J Chron Dis 40:59?69, 1987.","journal-title":"J Chron Dis"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/bjc.1988.44","volume":"57","author":"TJA Key","year":"1988","unstructured":"Key TJA, Pike MC: The dose-effect relationship between ?unopposed? oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 57:205?212, 1988.","journal-title":"Br J Cancer"},{"key":"CR8","first-page":"292","volume-title":"Current Therapy in Oncology","author":"MC Pike","year":"1993","unstructured":"Pike MC, Bernstein L, Spicer DV: Exogenous hormones and breast cancer risk.In: Niederhuber JE (ed) Current Therapy in Oncology. B.D. Decker\/Mosby Year Book, St. Louis MO, 1993, pp 292?303."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/bjc.1989.237","volume":"60","author":"MC Pike","year":"1989","unstructured":"Pike MC, Ross RK, Lobo RA, Key TJA, Potts M, Henderson BE: LHRH agonists and the prevention of breast and ovarian cancer. Br J Cancer 60:142?148, 1989.","journal-title":"Br J Cancer"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0010-7824(91)90019-C","volume":"44","author":"DV Spicer","year":"1991","unstructured":"Spicer DV, Shoupe D, Pike M: GnRH agonists as contraceptive agents: Predicted significantly reduced risk of breast cancer. Contraception 44:289?310, 1991.","journal-title":"Contraception"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1126\/science.2136249","volume":"249","author":"BN Ames","year":"1990","unstructured":"Ames BN, Gold LS: Too many rodent carcinogens: Mitogenesis increases mutagenesis. Science 249:970?971, 1990.","journal-title":"Science"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.2204108","volume":"249","author":"SM Cohen","year":"1990","unstructured":"Cohen SM, Ellwein L: Cell proliferation in carcinogenesis. Science 249:1007?1011, 1990.","journal-title":"Science"},{"key":"CR13","first-page":"7415","volume":"50","author":"S Preston-Martin","year":"1990","unstructured":"Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE: Increased cell division as a cause of human cancer. Cancer Res 50:7415?7421, 1990.","journal-title":"Cancer Res"},{"key":"CR14","volume-title":"Chemically Induced Cell Proliferation: Implications for Risk Assessment","author":"B Butterworth","year":"1991","unstructured":"Butterworth B, Slaga T: Chemically Induced Cell Proliferation: Implications for Risk Assessment. Wiley-Liss, New York, 1991."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oxfordjournals.epirev.a036102","volume":"15","author":"MC Pike","year":"1993","unstructured":"Pike MC, Spicer DV, Dahmoush L, Press MF: Estrogens, progestogens, normal breast cell proliferation and breast cancer risk. Epidemiol Rev 15:17?35, 1993.","journal-title":"Epidemiol Rev"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0046-8177(77)80066-X","volume":"8","author":"JS Meyer","year":"1977","unstructured":"Meyer JS: Cell proliferation in normal human breast ducts, fibroadenomas, and other duct hyperplasias, measured by nuclear labeling with tritiated thymidine. Hum Pathol 8:67?81, 1977.","journal-title":"Hum Pathol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/bjc.1982.213","volume":"46","author":"TJ Anderson","year":"1982","unstructured":"Anderson TJ, Ferguson DJP, Raab GM: Cell turnover in the ?resting? human breast: influence of parity, contraceptive pill, age and laterality. Br J Cancer 46:376?382, 1982.","journal-title":"Br J Cancer"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00000478-198606000-00003","volume":"10","author":"TA Longacre","year":"1986","unstructured":"Longacre TA, Bartow SA: A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Path 10:382?393, 1986.","journal-title":"Am J Surg Path"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0046-8177(89)80003-6","volume":"20","author":"TJ Anderson","year":"1989","unstructured":"Anderson TJ, Battersby S, King RJB, McPherson K, Going JJ: Oral contraceptive use influences resting breast proliferation. Hum Pathol 20:1139?1144, 1989.","journal-title":"Hum Pathol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ijc.2910480209","volume":"48","author":"G Williams","year":"1991","unstructured":"Williams G, Anderson E, Howell A: Oral contraceptive use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer 48:206?210, 1991.","journal-title":"Int J Cancer"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF00718610","volume":"413","author":"A Battersby","year":"1988","unstructured":"Battersby A, Anderson TJ: Proliferative and secretory activity in the pregnant and lactating human breast. Virchows Archiv A Pathol Anat 413:189?196, 1988.","journal-title":"Virchows Archiv A Pathol Anat"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/1097-0142(19820815)50:4<746::AID-CNCR2820500420>3.0.CO;2-A","volume":"50","author":"JS Meyer","year":"1982","unstructured":"Meyer JS, Connor RE: Cell proliferation in fibrocystic disease and postmenopausal breast ducts measured by thymidine labeling. Cancer 50:746?751, 1982.","journal-title":"Cancer"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1210\/endo-122-2-464","volume":"122","author":"SZ Haslam","year":"1988","unstructured":"Haslam SZ: Progesterone effects on deoxyribonucleic acid synthesis in normal mouse mammary glands. Endocrinol 122:464?470, 1988.","journal-title":"Endocrinol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1210\/endo-127-5-2183","volume":"127","author":"S Wang","year":"1990","unstructured":"Wang S, Counterman LJ, Haslam SZ: Progesterone action in normal mouse mammary gland. Endocrinol 127:2183?2190, 1990.","journal-title":"Endocrinol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0012-1606(88)90317-X","volume":"127","author":"S Coleman","year":"1988","unstructured":"Coleman S, Silberstein GB, Daniel CW: Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor. Devel Biol 127:304?315, 1988.","journal-title":"Devel Biol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0012-1606(90)90267-M","volume":"137","author":"S Coleman","year":"1990","unstructured":"Coleman S, Daniel CW: Inhibition of mouse mammary ductal morphogenesis and down-regulation of the EGF receptor by epidermal growth factor. Devel Biol 137:425?433, 1990.","journal-title":"Devel Biol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jcp.1041550110","volume":"155","author":"SZ Haslam","year":"1993","unstructured":"Haslam SZ, Counterman LJ, Nummy KA: Effects of epidermal growth factor, estrogen and progestin on DNA synthesis in mammary cells in vivo are determined by the developmental state of the gland. J Cell Physiol 155:72?78, 1993.","journal-title":"J Cell Physiol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jcp.1041520315","volume":"152","author":"SZ Haslam","year":"1992","unstructured":"Haslam SZ, Counterman LJ, Nummy KA: EGF receptor regulation in normal mouse mammary gland. J Cell Physiol 152:553?557, 1992.","journal-title":"J Cell Physiol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0012-1606(92)90142-4","volume":"152","author":"GB Silberstein","year":"1992","unstructured":"Silberstein GB, Flanders KC, Roberts AB, Daniel CV: Regulation of mammary morphogenesis: evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor betal. Devel Biol 152:354?362, 1992.","journal-title":"Devel Biol"},{"key":"CR30","first-page":"315","volume-title":"Treatment of the Postmenopausal Woman: Basic and Clinical Aspects","author":"DV Spicer","year":"1994","unstructured":"Spicer DV, Pike MC: Epidemiology of breast cancer.In: Lobo RA (ed) Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. Raven Press, New York, 1994, pp 315?324."},{"key":"CR31","first-page":"1403","volume-title":"Origins of Human Cancer: Book C, Human Risk Assessment","author":"R Peto","year":"1977","unstructured":"Peto R: Epidemiology, multistage models, and shortterm mutagenicity tests.In: Hiatt HH, Watson JD, Winsten JE (eds) Origins of Human Cancer: Book C, Human Risk Assessment. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1977, pp 1403?1428."},{"key":"CR32","first-page":"605","volume":"48","author":"DB Trichopoulos","year":"1972","unstructured":"Trichopoulos DB, MacMahon B, Cole P: Menopause and breast cancer risk. J Natl Cancer Inst 48:605?613, 1972.","journal-title":"J Natl Cancer Inst"},{"key":"CR33","first-page":"315","volume":"41","author":"M Feinleib","year":"1968","unstructured":"Feinleib M: Breast cancer and artificial menopause: a cohort study. J Natl Cancer Inst 41:315?329, 1968.","journal-title":"J Natl Cancer Inst"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/1097-0142(196201\/02)15:1<28::AID-CNCR2820150105>3.0.CO;2-3","volume":"15","author":"T Hirayama","year":"1962","unstructured":"Hirayama T, Wynder EL: A study of the epidemiology of cancer of the breast. II. The influence of hysterectomy. Cancer 15:28?38, 1962.","journal-title":"Cancer"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/1097-0142(19850901)56:5<1206::AID-CNCR2820560541>3.0.CO;2-9","volume":"56","author":"BE Henderson","year":"1985","unstructured":"Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC: Do regular ovulatory cycles increase breast cancer risk? Cancer 56:1206?1208, 1985.","journal-title":"Cancer"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0002-9378(72)90687-4","volume":"113","author":"DR Mishell Jr","year":"1972","unstructured":"Mishell Jr DR, Kharma KM, Thorneycroft IH, Nakamura RM: Estrogenic activity in women receiving an injectable progestogen for contraception. Am J Obstet Gynecol 113:372?376, 1972.","journal-title":"Am J Obstet Gynecol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/00016347709158338","volume":"56","author":"S Jeppsson","year":"1977","unstructured":"Jeppsson S, Johansson EDB, Ljungberg O, Sjoberg N-O: Endometrial histology and circulating levels of medroxyprogesterone acetate (MPA). Estradiol, FSH and LH in women with MPA induced amenorrhoea compared with women with secondary amenorrhoea. Acta Obstet Gynecol Scand 56:43?48, 1977.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"CR38","first-page":"1247","volume":"79","author":"NC Lee","year":"1987","unstructured":"Lee NC, Rosero-Bixby L, Oberle MW, Grimaldo C, Whately AS, Rovira EZ: A case-control study of breast cancer and hormonal contraception in Costa Rica. J Natl Cancer Inst 79:1247?1254, 1987.","journal-title":"J Natl Cancer Inst"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/bmj.299.6702.759","volume":"299","author":"C Paul","year":"1989","unstructured":"Paul C, Skegg DCG, Spears GFS: Depot medroxyprogesterone (Depo-Provera) and risk of breast cancer. Br Med J 299:759?762, 1989.","journal-title":"Br Med J"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM198908033210505","volume":"321","author":"L Bergkvist","year":"1989","unstructured":"Bergkvist L, Adami H-O, Persson I, Hoover R, Schairer C: The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 321:293?297, 1989.","journal-title":"N Engl J Med"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0140-6736(92)93064-T","volume":"340","author":"I Persson","year":"1992","unstructured":"Persson I, Yuen J, Bergkvist L, Adami H-O, Hoover R, Schairer C: Combined oestrogen-progestogen replacement and breast cancer risk. Lancet 340:1044, 1992.","journal-title":"Lancet"},{"key":"CR42","first-page":"3289s","volume":"42","author":"B Zumoff","year":"1982","unstructured":"Zumoff B: Relationship of obesity to blood estrogens. Cancer Res 42:3289s-3294s, 1982.","journal-title":"Cancer Res"},{"key":"CR43","first-page":"288","volume-title":"Infertility, Contraception and Reproductive Endocrinology","author":"D Shoupe","year":"1991","unstructured":"Shoupe D. Effect of body weight on reproductive function.In: Mishell DR Jr, Davajan V, Lobo RA (eds) Infertility, Contraception and Reproductive Endocrinology, third ed. Blackwell Scientific Publications, Boston, 1991, pp 288?316.","edition":"third ed."},{"key":"CR44","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/303767a0","volume":"303","author":"M Pike","year":"1983","unstructured":"Pike M, Krailo M, Henderson B, Casagrande J, Hoel D: ?Hormonal? risk factors, ?breast tissue age? and the age-incidence of breast cancer. Nature 303:767?770, 1983.","journal-title":"Nature"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ijc.2910140204","volume":"14","author":"B MacMahon","year":"1974","unstructured":"MacMahon B, Cole P, Brown JB, Aoki K, Lin TM, Morgan RW, Woo N-C: Urine estrogen profiles of Asian and North American Women. Int J Cancer 14:161?167, 1974.","journal-title":"Int J Cancer"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ajcn\/44.6.945","volume":"44","author":"BR Goldin","year":"1986","unstructured":"Goldin BR, Adlercreutz H, Gorbach SL, Woods MN, Dwyer JT, Conlon T, Bohn E, Gershoff SN: The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am J Clin Nutr 44:945?953, 1986.","journal-title":"Am J Clin Nutr"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00053183","volume":"1","author":"L Bernstein","year":"1990","unstructured":"Bernstein L, Yuan J-M, Ross RK, Pike MC, Lobo RA, Stanczyk F, Gao Y-T, Henderson BE: Serum hormone levels in premenopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies. Cancer Causes Control 1:51?58, 1990.","journal-title":"Cancer Causes Control"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/bjc.1990.344","volume":"62","author":"TJA Key","year":"1990","unstructured":"Key TJA, Chen J, Wang DY, Pike MC, Boreham J: Sex hormones in women in rural China and in Britain. Br J Cancer 62:631?636, 1990.","journal-title":"Br J Cancer"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0015-0282(16)45688-8","volume":"36","author":"G Tolis","year":"1981","unstructured":"Tolis G, Comaru-Schally A, Mehta A, Schally A: Failure to interrupt established pregnancy in humans by d-tryptophan-6-luteinizing hormone-releasing hormone. Fertil Steril 36:241?242, 1981.","journal-title":"Fertil Steril"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.377491","volume":"205","author":"R Casper","year":"1979","unstructured":"Casper R, Yen S: Induction of luteolysis in the human with a long-acting analog of luteinizing hormone-releasing factor. Science 205:408?410, 1979.","journal-title":"Science"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1126\/science.6797068","volume":"215","author":"K Sheehan","year":"1982","unstructured":"Sheehan K, Casper R, Yen S: Luteal phase defects induced by an agonist of luteinizing hormone-releasing factor: a model for fertility control. Science 215:170?172, 1982.","journal-title":"Science"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0010-7824(78)80005-5","volume":"17","author":"S Nillius","year":"1978","unstructured":"Nillius S, Bergquist C, Wide L: Inhibition of ovulation in women by chronic treatment with a stimulatory LHRH analogue ? a new approach to birth control. Contraception 17:537?545, 1978.","journal-title":"Contraception"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/03009738409178469","volume":"89","author":"C Bergquist","year":"1984","unstructured":"Bergquist C, Nillius S, Wide L: Peptide contraception in women. Upsala J Med Sci 89:99?106, 1984.","journal-title":"Upsala J Med Sci"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2265.1983.tb00039.x","volume":"19","author":"W Hardt","year":"1983","unstructured":"Hardt W, Schmidt-Gollwitzer M: Sustained gonadal suppression in fertile women with the LHRH agonist buserelin. Clin Endocrinol 19:613?617, 1983.","journal-title":"Clin Endocrinol"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0010-7824(81)90104-9","volume":"23","author":"M Schmidt-Gollwitzer","year":"1981","unstructured":"Schmidt-Gollwitzer M, Hardt W, Schmidt-Gollwitzer K, von der Ohe M, Nevinny-Stickel J: Influence of the LH-RH analogue buserelin on cyclic ovarian function and on endometrium. A new approach to fertility control? Contraception 23:187?195, 1981.","journal-title":"Contraception"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0010-7824(85)80001-9","volume":"32","author":"P Brenner","year":"1985","unstructured":"Brenner P, Shoupe D, Mishell D: Ovulation inhibition with nafarelin acetate nasal administration for six months. Contraception 32:531?551, 1985.","journal-title":"Contraception"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0015-0282(16)48614-0","volume":"43","author":"A LeMay","year":"1985","unstructured":"LeMay A, Faure N, Labrie F, Fazekas A: Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonists dosing in combination with gestagen-induced bleeding. Fertil Steril 43:868?877, 1985.","journal-title":"Fertil Steril"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2265.1984.tb03458.x","volume":"21","author":"H Kuhl","year":"1984","unstructured":"Kuhl H, Jung C, Taubert H: Contraception with an LHRH agonist: effect on gonadotrophin and steriod secretion patterns. Clin Endocrinol 21:179?188, 1984.","journal-title":"Clin Endocrinol"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0010-7824(93)90095-O","volume":"47","author":"DV Spicer","year":"1993","unstructured":"Spicer DV, Pike MC, Pike A, Rude R, Shoupe D, Richardson J: Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancer. Contraception 47:427?444, 1993.","journal-title":"Contraception"},{"key":"CR60","first-page":"6S","volume":"72","author":"PF Brenner","year":"1988","unstructured":"Brenner PF: The menopausal syndrome. Obstet Gynecol 72:6S-11S, 1988.","journal-title":"Obstet Gynecol"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0015-0282(16)47899-4","volume":"41","author":"A Lemay","year":"1984","unstructured":"Lemay A, Maheux R, Faure N, Jean C, Fazekas ATA: Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (buserelin) as a new therapeutic approach for endometriosis. Fertil Steril 41:863?871, 1984.","journal-title":"Fertil Steril"},{"key":"CR62","first-page":"403","volume":"69","author":"K Steingold","year":"1987","unstructured":"Steingold K, Cedars M, Lu J, Randle D, Judd H, Meldrum D: Treatment of endometriosis with a longacting gonadotropin-releasing hormone agonist. Obstet Gynecol 69:403?411, 1987.","journal-title":"Obstet Gynecol"},{"key":"CR63","first-page":"19","volume":"34","author":"M George","year":"1989","unstructured":"George M, Lhomme C, Lefort J, Gras C, Comoru-Schally A, Schally A: Long-term use of an LHRH agonist in the management of uterine leiomyomas: a study of 17 cases. Int J Fertil 34:19?24, 1989.","journal-title":"Int J Fertil"},{"key":"CR64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/00016348909087689","volume":"68","author":"L Ronnberg","year":"1989","unstructured":"Ronnberg L, Koskimies A, Laatikainen T, Ranta T, Saastamoinen J: Efficacy of gonadotropin-releasing hormone agonist (buserelin) in the treatment of endometriosis. Acta Obstet Gynecol Scand 68:49?53, 1989.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"CR65","first-page":"115","volume-title":"Menopause, Physiology and Pharmacology","author":"L Dennerstein","year":"1987","unstructured":"Dennerstein L: Psychologic changes.In: Mishell D Jr (ed) Menopause, Physiology and Pharmacology. Yearbook Medical Publishers, Chicago, 1987, pp 115?126."},{"key":"CR66","first-page":"141","volume-title":"Menopause, Physiology and Pharmacology","author":"D Meldrum","year":"1987","unstructured":"Meldrum D: Treatment of hot flushes.In: Mishell D Jr (ed) Menopause, Physiology and Pharmacology. Yearbook Medical Publishers, Chicago, 1987, pp 141?150."},{"key":"CR67","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1136\/bmj.293.6558.1337","volume":"293","author":"PL Selby","year":"1986","unstructured":"Selby PL, Peacock M: Dose dependent response of symptoms, pituitary, and bone to transdermal estrogen in postmenopausal women. Br Med J 293:1337?1339, 1986.","journal-title":"Br Med J"},{"key":"CR68","first-page":"1","volume":"63","author":"RA Lobo","year":"1984","unstructured":"Lobo RA, McCormick W, Singer F, Roy S: Depomedroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women. Obstet Gynecol 63:1?5, 1984.","journal-title":"Obstet Gynecol"},{"key":"CR69","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/00016348509155154","volume":"64","author":"S Hammarback","year":"1985","unstructured":"Hammarback S, Backstrom T, Holst J, von Schoultz B, Lyrenas S: Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestogen postmenopausal replacement therapy. Acta Obstet Gynecol Scand 64:393?397, 1985.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"CR70","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1471-0528.1986.tb07868.x","volume":"93","author":"AL Magos","year":"1986","unstructured":"Magos AL, Brewster E, Singh R, O'Dowd T, Brincat M, Studd JW: The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. Br J Obstet Gynaecol 93:1290?1296, 1986.","journal-title":"Br J Obstet Gynaecol"},{"key":"CR71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0378-5122(89)90116-3","volume":"11","author":"J Holst","year":"1989","unstructured":"Holst J, Backstrom T, Hammarback S, Schoultz BV: Progestogen addition during estrogen replacement therapy ? effects on vasomotor symptoms and mood. Maturitas 11:13?20, 1989.","journal-title":"Maturitas"},{"key":"CR72","unstructured":"Mezrow G, Shoupe D, Spicer D, Pike M: Depot leuprolide acetate (GnRH) with estrogen and progestin addback for longterm treatment of premenstrual syndrome. Society for Gynecologic Investigation, 1992."},{"key":"CR73","first-page":"839","volume-title":"Infertility, Contraception and Reproductive Endocrinology","author":"DR Mishell Jr","year":"1991","unstructured":"Mishell DR Jr: Oral steroid contraceptives.In: Mishell D Jr, Davajan V, Lobo RA (eds) Infertility, Contraception and Reproductive Endocrinology (3d ed). Blackwell Scientific Publications, Boston, 1991, pp 839?871.","edition":"3d ed"},{"key":"CR74","first-page":"9","volume":"49","author":"B Henderson","year":"1988","unstructured":"Henderson B, Ross R, Lobo R, Pike M, Mack T: Reevaluating the role of progestogen therapy after the menopause. Fertil Steril 49 (Suppl):9?15, 1988.","journal-title":"Fertil Steril"},{"key":"CR75","first-page":"187","volume-title":"Menopause, Physiology and Pharmacology","author":"T Bush","year":"1987","unstructured":"Bush T, Miller V: Effects of pharmacologic agents used during menopause: impact on lipids and lipoproteins.In: Mishell D Jr (ed) Menopause, Physiology and Pharmacology. Yearbook Medical Publishers, Chicago, 1987, pp 187?208."},{"key":"CR76","first-page":"91","volume-title":"Menopause, Physiology and Pharmacology","author":"W Kannel","year":"1987","unstructured":"Kannel W, Gordon T: Cardiovascular effects of the menopause.In: Mishell D Jr (ed) Menopause, Physiology and Pharmacology. Yearbook Medical Publishers, Chicago, 1987, pp 91?102."},{"key":"CR77","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1136\/bmj.296.6638.1702","volume":"296","author":"J Mann","year":"1988","unstructured":"Mann J, Lewis B, Shepherd J, Winder A, Fenster S, Rose L, Morgan B: Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain. Br Med J 296:1702?1706, 1988.","journal-title":"Br Med J"},{"key":"CR78","unstructured":"Liskin L, Blackburn R: Hormonal contraception: new long-acting methods. Popul Rep Series K(3), 1987."},{"key":"CR79","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2106\/00004623-198466070-00007","volume":"66","author":"P Ruegsegger","year":"1984","unstructured":"Ruegsegger P, Dambacher MA, Ruegsegger E, Fischer JA, Anliker M: Bone loss in premenopausal and postmenopausal women. J Bone and Joint Surg 66:1015?1023, 1984.","journal-title":"J Bone and Joint Surg"},{"key":"CR80","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2362.1988.tb01052.x","volume":"18","author":"L Nilas","year":"1988","unstructured":"Nilas L, Christiansen C: Rates of bone loss in normal women: evidence of accelerated trabecular bone loss after the menopause. Eur J Clin Invest 18:529?534, 1988.","journal-title":"Eur J Clin Invest"},{"key":"CR81","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1172\/JCI110667","volume":"70","author":"B Riggs","year":"1982","unstructured":"Riggs B, Wahner H, Seeman E, Offord K, Dunn W, Mazess R, Johnson K, Melton L: Changes in bone mineral density of the proximal femur and spine with aging. J Clin Invest 70:716?723, 1982.","journal-title":"J Clin Invest"},{"key":"CR82","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0169-6009(91)90092-E","volume":"14","author":"BL Drinkwater","year":"1991","unstructured":"Drinkwater BL, Chesnut CH III: Bone density changes during pregnancy and lactation in active women: a longitudinal study. Bone Miner 14:153?160, 1991.","journal-title":"Bone Miner"},{"key":"CR83","first-page":"588","volume":"73","author":"CC Hayslip","year":"1989","unstructured":"Hayslip CC, Klein TA, Wray HL, Duncan WE: The effects of lactation on bone mineral content in healthy postpartum women. Obstet Gynecol 73:588?592, 1989.","journal-title":"Obstet Gynecol"},{"key":"CR84","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1001\/jama.1993.03500240074029","volume":"269","author":"M Sowers","year":"1993","unstructured":"Sowers M, Corton G, Shapiro B, Jannausch ML, Crutchfield M, Smith ML, Randolph JF, Hollis B: Changes in bone density with lactation. JAMA 269:3130?3135, 1993.","journal-title":"JAMA"},{"key":"CR85","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/ajcn\/48.6.1479","volume":"48","author":"CA Koetting","year":"1988","unstructured":"Koetting CA, Wardlaw GM: Wrist, spine, and hip bone density in women with variable histories of lactation. Am J Clin Nutr 48:1479?1481, 1988.","journal-title":"Am J Clin Nutr"},{"key":"CR86","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.303.6793.13","volume":"303","author":"T Cundy","year":"1991","unstructured":"Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid I: Bone density in women receiving depot medroxyprogesterone acetate for contraception. Br Med J 303:13?16, 1991.","journal-title":"Br Med J"},{"key":"CR87","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2265.1988.tb00248.x","volume":"29","author":"WH Matta","year":"1988","unstructured":"Matta WH, Shaw RW, Hesp R, Evans R: Reversible trabecular bone density loss following induced hypooestrogenism with the GnRH analogue buserelin in premenopausal women. Clin Endocrin 29:45?51, 1988.","journal-title":"Clin Endocrin"},{"key":"CR88","first-page":"165","volume-title":"Menopause, Physiology and Pharmacology","author":"RA Lobo","year":"1987","unstructured":"Lobo RA: Prevention of postmenopausal osteoporosis.In: Mishell D Jr (ed) Menopause, Physiology and Pharmacology. Yearbook Medical Publishers, Chicago, 1987, pp 165?186."},{"key":"CR89","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/0003-4819-106-1-40","volume":"106","author":"B Ettinger","year":"1987","unstructured":"Ettinger B, Genant H, Cann C: Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Int Med 106:40?45, 1987.","journal-title":"Ann Int Med"},{"key":"CR90","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7326\/0003-4819-97-5-699","volume":"97","author":"H Genant","year":"1982","unstructured":"Genant H, Cann C, Ettinger B, Gordan G: Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 97:699?705, 1982.","journal-title":"Ann Intern Med"},{"key":"CR91","first-page":"82","volume-title":"Effects of oral esterified estrogens and esterified estrogens + androgen on bone mineral denisty in postmenopausal women. The North American Menopause Society, 2nd Annual Meeting","author":"N Watts","year":"1991","unstructured":"Watts N, Notelovits M, Timmons C, Addison W, Wiita B, Downey L: Effects of oral esterified estrogens and esterified estrogens + androgen on bone mineral denisty in postmenopausal women. The North American Menopause Society, 2nd Annual Meeting. Montreal, Canada, 1991, 82."},{"key":"CR92","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1210\/jcem-65-4-773","volume":"65","author":"K Steingold","year":"1987","unstructured":"Steingold K, De Ziegler D, Cedars M, Meldrum DR, Lu JKH, Judd HL, Chang RJ: Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease. J Clin Endorinol Metab 65:773?778, 1987.","journal-title":"J Clin Endorinol Metab"},{"key":"CR93","first-page":"25","volume":"54","author":"JWW Studd","year":"1978","unstructured":"Studd JWW, Chakravarti S, Collins WP: Plasma hormone profiles after the menopause and bilateral oophorectomy. Postgrad Med J 54:25?30, 1978.","journal-title":"Postgrad Med J"},{"key":"CR94","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/jcem-64-3-513","volume":"64","author":"Longcope","year":"1987","unstructured":"Longcope, Hui, Johnston: Free estradiol, free testosterone, and sex hormone-binding globulin in perimenopausal women. J Clin Endocrinol Metab 64:513?518, 1987.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR95","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1210\/jcem-69-3-533","volume":"69","author":"K Steinberg","year":"1989","unstructured":"Steinberg K, Freni-Titulaer LW, DePuey E, Miller D, Sgoutas D, Coralli C, Phillips D, Rogers T, Clark R: Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab 69:533?39, 1989.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR96","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-94-011-7230-1_13","volume-title":"The Menopause and Postmenopause","author":"J Studd","year":"1980","unstructured":"Studd J, Thom M, Paterson M: The prevention and treatment of endometrial pathology in postmenopausal women receiving exogenous oestrogens.In: Pasetto W, Pavletti R, Lambrus J (eds) The Menopause and Postmenopause. MTP Press, Lancaster UK, 1980, pp 127?138."},{"key":"CR97","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-2007-1022574","volume":"1","author":"M Whitehead","year":"1983","unstructured":"Whitehead M, Lane G, Siddle N, Townsend P, King R: Avoidance of endometrial hyperstimulation in estrogen-treated postmenopausal women. Semin Reprod Endocrinol 1:41?54, 1983.","journal-title":"Semin Reprod Endocrinol"},{"key":"CR98","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0015-0282(16)45981-9","volume":"37","author":"I Schiff","year":"1982","unstructured":"Schiff I, Sela H, Cramer D, Tulchinsky D, Ryan K: Endometrial hyperplasia in women on cyclic or continuous estrogen regimens. Fertil Steril 37:79?82, 1982.","journal-title":"Fertil Steril"},{"key":"CR99","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0015-0282(16)59670-8","volume":"49","author":"W Matta","year":"1988","unstructured":"Matta W, Shaw R, Burford G: Endocrinologic and clinical evaluation following a single administration of a gonadotrophin-releasing hormone agonist (Zoladex), in a depot formulation, to premenopausal women. Fertil Steril 49:163?165, 1988.","journal-title":"Fertil Steril"},{"key":"CR100","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0015-0282(16)61022-1","volume":"52","author":"A Friedman","year":"1989","unstructured":"Friedman A, Rein M, Harrison-Atlas D, Garfield J, Doubilet P: A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy. Fertil Steril 52:728?733, 1989.","journal-title":"Fertil Steril"},{"key":"CR101","first-page":"856","volume":"74","author":"W Schlaff","year":"1989","unstructured":"Schlaff W, Zerhouni E, Huth J, Chen J, Damewood M, Rock J: A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata. Obstet Gynecol 74:856?862, 1989.","journal-title":"Obstet Gynecol"},{"key":"CR102","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0015-0282(16)53330-5","volume":"53","author":"J-R Zorn","year":"1990","unstructured":"Zorn J-R, Mathieson J, Risquez F, Comaru-Schally A, Schally A: Treatment of endometriosis with a delayed release preparation of the agonist D-Trp-luteinizing hormone-releasing hormone: long-term follow-up in a series of 50 patients. Fertil Steril 53:401?406, 1990.","journal-title":"Fertil Steril"},{"key":"CR103","first-page":"191","volume":"49","author":"JL Stanford","year":"1991","unstructured":"Stanford JL, Thomas DB: Depot-medroxyprogester-one acetate (DMPA) and risk of epithelial ovarian cancer. Int J Cancer 49:191?195, 1991.","journal-title":"Int J Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00666430.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00666430\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00666430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T07:33:36Z","timestamp":1554449616000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00666430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993]]},"references-count":103,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1993]]}},"alternative-id":["BF00666430"],"URL":"https:\/\/doi.org\/10.1007\/bf00666430","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993]]}}}